MedTrace Logo

Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit

NCT01948505 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2023-04-24

Study results available
· View outcomes & findings →

Summary

To assess the efficacy of an intravenous nonnarcotic pain medication on controlling patient pain.

To assess the effect of an intravenous nonnarcotic pain medication on patient sedation levels in neurocritically ill patients.

To assess the effect of an intravenous nonnarcotic pain medication on common side effects seen in patients taking other intravenous narcotic pain medication in the neurocritical care unit.

Conditions

  • Post-operative Craniotomy Patients
  • Carotid Endarterectomy and Carotid Artery Stenosis Patients
  • Post-op Spine Patients Admitted to the NCCU
  • Endovascular Patients Undergoing Intracranial Intervention
  • Traumatic Brain Injuries NPO for at Least 12 Hours

Interventions

DRUG

Intravenous acetaminophen

DRUG

Placebo for IV acetaminophen

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-11-30
Completion
2016-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01948505 on ClinicalTrials.gov